Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue

Prostate

Volumn 69, Issue 8, 2009, Pages 810-819

  Walton, Thomas J ^a,b   Li, Geng ^a   McCulloch, Thomas A ^b   Seth, Rashmi ^c   Powe, Desmond G ^c   Bishop, Michael C ^b   Rees, Robert C ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Estrogen receptor; Gene expression; Methodology; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; DNA; ESTROGEN RECEPTOR; PRIMER DNA; RNA;

ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOWN REGULATION; ELECTROPHORESIS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATECTOMY; QUANTITATIVE ANALYSIS; RANK SUM TEST; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; DISSECTION; GENETIC TRANSCRIPTION; GENETICS; ISOLATION AND PURIFICATION; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE TUMOR; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

DISSECTION; DNA PRIMERS; DNA, NEOPLASM; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSCRIPTION, GENETIC;

EID: 65549136111     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20929     Document Type: Article

References (56)

1. Levi F, Lucchini F, Negri E, La Vecchia C. Continuing declines in cancer mortality in the European Union. Ann Oncol 2007;18(3):593-595. (Pubitemid 46359644)
2. Stewart SL, King JB, Thompson TD, Friedman C, Wingo PA. Cancer mortality surveillance-United States, 1990-2000. MMWR Surveill Summ 2004;53(3):1-108.
3. Huggins C, Hodges C. Studies on prostatic cancer I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941;1:293-298.
4. el-Rayes BF, Hussain MH. Hormonal therapy for prostate cancer: Past, present and future. Expert Rev Anticancer Ther 2002;2(1):37-47.
5. Landstrom M, Bergh A, Thornell LE, Virtanen I, Damber JE. Estrogen treatment of Dunning tumors in castrated rats: Qualitative and quantitative morphology. Prostate 1992;20(3):199-211.
6. Jarred RA, Cancilla B, Prins GS, Thayer KA, Cunha GR, Risbridger GP. Evidence that estrogens directly alter androgen-regulated prostate development. Endocrinology 2000;141(9):3471-3477. (Pubitemid 32269037)
7. Ferro MA. Use of intravenous stilbestrol diphosphate in patients with prostatic carcinoma refractory to conventional hormonal manipulation. Urol Clin North Am 1991;18(1):139-143.
8. Smith DC, Redman BG, Flaherty LE, Li L, Strawderman M, Pienta KJ. A phase II trial of oral diethylstilbesterol as a secondline hormonal agent in advanced prostate cancer. Urology 1998;52(2):257-260. (Pubitemid 28357829)
9. Bonkhoff H, Fixemer T, Hunsicker I, Remberger K. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. Am J Pathol 1999;155(2):641-647. (Pubitemid 29370414)
10. Ehara H, Koji T, Deguchi T, Yoshii A, Nakano M, Nakane PK, Kawada Y. Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 1995;27(6):304-313.
11. Schulze H, Claus S. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate 1990;16(4):331-343. (Pubitemid 20297321)
12. Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 2001;159(1):79-92. (Pubitemid 33704195)
13. Royuela M, de Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile B, Arenas MI, Paniagua R. Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate. J Endocrinol 2001;168(3):447-454. (Pubitemid 32241889)
14. Griffiths K. Estrogens and prostatic disease. International Prostate Health Council Study Group. Prostate 2000;45(2):87-100.
15. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93(12):5925-5930. (Pubitemid 26190778)
16. Mosselman S, Polman J, Dijkema R. ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett 1996;392(1):49-53.
17. Tsurusaki T, Aoki D, Kanetake H, Inoue S, Muramatsu M, Hishikawa Y, Koji T. Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia. J Clin Endocrinol Metab 2003;88(3):1333-1340. (Pubitemid 36337798)
18. Adams JY, Leav I, Lau KM, Ho SM, Pflueger SM. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate. Prostate 2002;52(1):69-81. (Pubitemid 34553193)
19. De Marzo AM, Meeker AK, Epstein JI, Coffey DS. Prostate stem cell compartments: Expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am J Pathol 1998;153(3):911-919.
20. Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: An overview and update. Nucl Recept Signal 2008;6:e003.
21. Chang WY, Prins GS. Estrogen receptor-beta: Implications for the prostate gland. Prostate 1999;40(2):115-124.
22. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M, Gustafsson JA. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001;98(11):6330-6335. (Pubitemid 32492315)
23. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998;95(26):15677- 15682. (Pubitemid 29018759)
24. Lau KM, LaSpina M, Long J, Ho SM. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 2000;60(12):3175-3182.
25. Poelzl G, Kasai Y, Mochizuki N, Shaul PW, Brown M, Mendelsohn ME. Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, MAD2. Proc Natl Acad Sci USA 2000;97(6):2836-2839. (Pubitemid 30159258)
26. Weihua Z, Warner M, Gustafsson JA. Estrogen receptor beta in the prostate. Mol Cell Endocrinol 2002;193(1-2):1-5.
27. Cheng G, Weihua Z, Makinen S, Makela S, Saji S, Warner M, Gustafsson JA, Hovatta O. A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary. Biol Reprod 2002;66(1):77-84. (Pubitemid 34023588)
28. Ogawa S, Chan J, Chester AE, Gustafsson JA, Korach KS, Pfaff DW. Survival of reproductive behaviors in estrogen receptor beta gene-deficient (betaERKO) male and female mice. Proc Natl Acad Sci USA 1999;96(22):12887-12892. (Pubitemid 29513598)
29. Bektic J, Berger AP, Pfeil K, Dobler G, Bartsch G, Klocker H. Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta. Eur Urol 2004;45(2):245-251; discussion 251. (Pubitemid 38147834)
30. Montano MM, Jaiswal AK, Katzenellenbogen BS. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta. J Biol Chem 1998;273(39):25443-25449. (Pubitemid 28443313)
31. Pasquali D, Staibano S, Prezioso D, Franco R, Esposito D, Notaro A, De Rosa G, Bellastella A, Sinisi AA. Estrogen receptor beta expression in human prostate tissue. Mol Cell Endocrinol 2001;178(1-2):47-50. (Pubitemid 32515349)
32. Nojima D, Li LC, Dharia A, Perinchery G, Ribeiro-Filho L, Yen TS, Dahiya R. CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma. Cancer 2001;92(8):2076-2083. (Pubitemid 32973317)
33. Ito T, Tachibana M, Yamamoto S, Nakashima J, Murai M. Expression of estrogen receptor (ER-alpha and ER-beta) mRNA in human prostate cancer. Eur Urol 2001;40(5):557-563. (Pubitemid 34289757)
34. Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao Y, McNeal JE, Ho SM. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. Am J Pathol 2004;164(6):2003-2012.
35. Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 2001;61(14):5331-5335. (Pubitemid 32694904)
36. Ji Q, Liu PI, Elshimali Y, Stolz A. Frequent loss of estrogen and progesterone receptors in human prostatic tumors determined by quantitative real-time PCR. Mol Cell Endocrinol 2005;229(1-2):103-110. (Pubitemid 40018088)
37. Fixemer T, Remberger K, Bonkhoff H. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 2003;54(2):79-87. (Pubitemid 36120323)
38. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials 1990;11(2):116-128.
39. Walton TJ, McCulloch TA, Rees RC, Bishop MC. Obtaining fresh prostate cancer tissue for research: A novel biopsy needle and sampling technique for radical prostatectomy specimens. Prostate 2005;64(4):382-386.
40. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA. Laser capture microdissection. Science 1996;274(5289):998- 1001.
41. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25(2):169-193.
42. Zhong H, Simons JW. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun 1999;259(3):523-526. (Pubitemid 29335566)
43. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3(7):RESEARCH0034.
44. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996;29(2):117-134. (Pubitemid 26287111)
45. Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi OP. Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 1997;57(2):314-319.
46. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995;55(2):342-347.
47. Latil A, Bieche I, Vidaud D, Lidereau R, Berthon P, Cussenot O, Vidaud M. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res 2001;61(5):1919-1926. (Pubitemid 32692008)
48. Brolin J, Skoog L, Ekman P. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate 1992;20(4):281-295. (Pubitemid 23005119)
49. Erenburg I, Schachter B, Mira y Lopez R, Ossowski L. Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: Interference with estrogen-stimulated properties of malignant transformation. Mol Endocrinol 1997;11(13):2004-2015.
50. Puddefoot JR, Baker VA, Bakkers B, Marsigliante S, Barker S, Panahy C, Goode AW, Carpenter R, Vinson GP. The nature and significance of multiple isoforms of the oestrogen receptor in breast tumours. J Mol Endocrinol 1993;11(1):83-90. (Pubitemid 23297954)
51. Torlakovic E, Lilleby W, Torlakovic G, Fossa SD, Chibbar R. Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score. Hum Pathol 2002;33(6):646-651.
52. Linja MJ, Savinainen KJ, Tammela TL, Isola JJ, Visakorpi T. Expression of ERalpha and ERbeta in prostate cancer. Prostate 2003;55(3):180-186. (Pubitemid 36532396)
53. Maruyama S, Fujimoto N, Asano K, Ito A, Usui T. Expression of estrogen receptor alpha and beta mRNAs in prostate cancers treated with leuprorelin acetate. Eur Urol 2000;38(5):635-639.
54. Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T, Muramatsu M, Inoue S. Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer. Biochem Biophys Res Commun 2001;289(3):692-699. (Pubitemid 33152289)
55. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM, Willson TM. Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 1998;247(1):75-78. (Pubitemid 28412528)
56. Thellenberg-Karlsson C, Lindstrom S, Malmer B, Wiklund F, Augustsson-Balter K, Adami HO, Stattin P, Nilsson M, Dahlman-Wright K, Gustafsson JA, Gronberg H. Estrogen receptor beta polymorphism is associated with prostate cancer risk. Clin Cancer Res 2006;12(6):1936-1941.